Specialized in AI-powered enzyme engineering
and production optimization
GeneChem is a global biotechnology company dedicated to enhancing human health and quality of life. Through cutting-edge research and development in AI-driven enzyme engineering, we lead the production and optimization of high-value biotechnological materials.
Leveraging our proprietary AI-based enzyme engineering platform, GeneChem efficiently designs, mass-produces, and commercializes safe and functional biomolecules found in nature. Our achievements include the development of high-performance PH20 variants, and the world’s first successful commercialization of sialyllactose-a Human Milk
Oligosaccharide(HMO). We have also pioneered the development of DSLNT and rare HMOs such as LST, LNFP, and LNDFHS.
Evolved through AI, GeneChem’s enzyme engineering technology is a unique and proprietary platform applicable not only to biopharmaceuticals but also to industries such as food and cosmetics. Proven for its safety and efficiency through AI-driven analysis, this platform continues to drive scientifically grounded innovation through both academic and industrial research.
By expanding the potential of enzyme technology through AI integration, we are strengthening the competitiveness of new business ventures. GeneChem will continue to contribute to human health and well-being through AI-powered, scientifically validated innovation.
